Compare ENTA & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENTA | MCFT |
|---|---|---|
| Founded | 1995 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.6M | 385.5M |
| IPO Year | 2012 | 2015 |
| Metric | ENTA | MCFT |
|---|---|---|
| Price | $15.22 | $27.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $20.40 | ★ $24.25 |
| AVG Volume (30 Days) | ★ 123.3K | 114.7K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.93 | N/A |
| EPS | N/A | ★ 0.33 |
| Revenue | $102,814,000.00 | ★ $284,203,000.00 |
| Revenue This Year | $7.76 | $9.18 |
| Revenue Next Year | N/A | $8.23 |
| P/E Ratio | ★ N/A | $67.16 |
| Revenue Growth | ★ 16.48 | N/A |
| 52 Week Low | $5.55 | $16.46 |
| 52 Week High | $17.15 | $26.49 |
| Indicator | ENTA | MCFT |
|---|---|---|
| Relative Strength Index (RSI) | 67.77 | 76.85 |
| Support Level | $12.91 | $19.79 |
| Resistance Level | $15.37 | N/A |
| Average True Range (ATR) | 0.76 | 1.00 |
| MACD | 0.16 | 0.32 |
| Stochastic Oscillator | 81.47 | 86.16 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.